Oramed Pharmaceuticals Inc. (ORMP) stock
ORMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/30
$3.71−0.32 (-7.94%)
Close on Nov 13, 2026Market cap $154.33MP/E 1.1Yield 6.74%
Oramed Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Oramed Pharmaceuticals's cash was $29.52M at Sep 30, 2026. For fiscal 2025 it was $51.36M, down 11.2% from the year before. Over ten years it grew 33.7% a year on average. The highest annual figure on record is $83.10M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $51.36M | -11.2% |
| FY2024 | Dec 31, 2024 | $57.86M | -13.3% |
| FY2023 | Dec 31, 2023 | $66.77M | -19.6% |
| FY2021 | Aug 31, 2021 | $83.10M | +267.8% |
| FY2020 | Aug 31, 2020 | $22.59M | +221.4% |
| FY2019 | Aug 31, 2019 | $7.03M | -26.7% |
| FY2018 | Aug 31, 2018 | $9.59M | +40.4% |
| FY2017 | Aug 31, 2017 | $6.83M | +1.0% |
| FY2016 | Aug 31, 2016 | $6.76M | +27.6% |
| FY2015 | Aug 31, 2015 | $5.30M | +88.7% |
| FY2014 | Aug 31, 2014 | $2.81M | -13.0% |
| FY2013 | Aug 31, 2013 | $3.23M | -30.3% |
| FY2012 | Aug 31, 2012 | $4.63M | +144.1% |
| FY2011 | Aug 31, 2011 | $1.90M | +58.2% |
| FY2010 | Aug 31, 2010 | $1.20M | -30.1% |
| FY2009 | Aug 31, 2009 | $1.72M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | $29.52M | -48.3% |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $16.09M | -8.3% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $18.17M | -76.8% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $51.36M | -11.2% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $57.14M | -42.6% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $17.55M | -88.4% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $78.21M | -18.8% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $57.86M | -13.3% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $99.56M | +1704.5% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $150.96M | +1858.0% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $96.31M | +265.2% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $66.77M | -19.6% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $5.52M | -91.5% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $7.71M | -79.1% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $26.37M | +46.9% |
| Q4 FY2021CQ3 2021 | Aug 31, 2021 | $83.10M | +267.8% |
| Q3 FY2021CQ2 2021 | May 31, 2021 | $64.62M | +412.5% |
| Q2 FY2021CQ1 2021 | Feb 28, 2021 | $36.81M | +303.0% |
| Q1 FY2021CQ4 2020 | Nov 30, 2020 | $17.95M | +181.4% |
| Q4 FY2020CQ3 2020 | Aug 31, 2020 | $22.59M | +221.4% |
| Q3 FY2020CQ2 2020 | May 31, 2020 | $12.61M | +54.4% |
| Q2 FY2020CQ1 2020 | Feb 29, 2020 | $9.13M | +2.6% |
| Q1 FY2020CQ4 2019 | Nov 30, 2019 | $6.38M | -33.5% |
| Q4 FY2019CQ3 2019 | Aug 31, 2019 | $7.03M | -4.8% |
| Q3 FY2019CQ2 2019 | May 31, 2019 | $8.17M | +25.2% |
| Q2 FY2019CQ1 2019 | Feb 28, 2019 | $8.90M | +123.7% |
| Q4 FY2018CQ3 2018 | Aug 31, 2018 | $9.59M | +40.4% |
| Q3 FY2018CQ2 2018 | May 31, 2018 | $7.38M | +53.7% |
| Q2 FY2018CQ1 2018 | Feb 28, 2018 | $6.52M | +29.0% |
| Q1 FY2018CQ4 2017 | Nov 30, 2017 | $3.98M | -33.4% |
| Q4 FY2017CQ3 2017 | Aug 31, 2017 | $6.83M | +1.0% |
| Q3 FY2017CQ2 2017 | May 31, 2017 | $4.81M | -27.9% |
| Q2 FY2017CQ1 2017 | Feb 28, 2017 | $5.06M | -4.7% |
| Q1 FY2017CQ4 2016 | Nov 30, 2016 | $5.98M | +52.0% |
| Q4 FY2016CQ3 2016 | Aug 31, 2016 | $6.76M | +27.6% |
| Q3 FY2016CQ2 2016 | May 31, 2016 | $6.67M | +44.7% |
| Q2 FY2016CQ1 2016 | Feb 29, 2016 | $5.31M | – |
| Q1 FY2016CQ4 2015 | Nov 30, 2015 | $3.93M | – |
| Q4 FY2015CQ3 2015 | Aug 31, 2015 | $5.30M | – |
| Q3 FY2015CQ2 2015 | May 31, 2015 | $4.61M | – |
See a number that looks wrong?